Skip to main content
Premium Trial:

Request an Annual Quote

Insilicos Awarded $400K to Develop Heart Disease Diagnostics

NEW YORK, March 13 (GenomeWeb News) - The National Heart, Lung, and Blood Institute has awarded Insilicos a two-year, $400,000 grant to develop a blood test for heart disease, the company said today.


Insilicos said it would use patent-pending computational and biological methods to analyze blood samples for the test, which will help identify patients at risk for heart attacks.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.